Clinical Pharmacokinetics Study on Pikamilone

Chinese Academy of Sciences

Status: Completed

Conditions: Healthy

Study type: Observational

Funder types: Other

Identifiers

NCT00940186

SIMM-DMPK-080901

Details and patient eligibility

About

Study on the phamacokinetics of Pikamilone in healthy Chinese subject and provide informations for further phase II study.

Enrollment: 30 patients

Sex: All

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• nonsmokers and in good health
• weight: BMI: 19-24
• written informed consent was finished.

Exclusion criteria

• disease
• taking any drug, alcohol, foods containing caffeine, or grapefruits and juice before study.

Trial design

30 participants in 3 patient groups

pikamilone

dosage

Description:

low dosage group: administrate pikamilone tablet 50 mg; middle dosage group: administrate pikamilone tablet 100 mg; hige dosage group: administrate pikamilone tablet 200 mg.

tablet